Scholarlink

Objective <p>To determine the role of whole-body dynamic (WBD)/Patlak parametric <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with alveolar echinococcosis (AE). This technique allows separating metabolized from unmetabolized FDG in the blood pool and tissue, potentially providing complementary qualitative information and superior quantification to standard static PET/CT images.</p> Methods <p>We prospectively analyzed 20 PET/CT datasets performed for staging or therapy monitoring in patients with confirmed AE. Dynamic and standard static PET/CT datasets were acquired in all patients, and quantitative imaging parameters were measured in the lesion with the highest uptake (i.e., maximum standardized uptake value (SUVmax) and Patlak parameters) and compared to normal liver tissue (SUVratio and Patlak ratio).</p> Results <p>Mean SUVmax in AE manifestations was 5.7 ± 3.1 (3.2–13.9), compared to 3.2 ± 0.4 (2.5–4.2) in non-infected liver tissue, respective values for Patlak were 13.0 ± 8.6 (2.7–35.5) and 4.9 ± 2.8 (0.6–12.1). SUVratio (1.8 ± 1.1; 1.0–5.2) was significantly lower (<i>P</i> &lt; 0.001) than Patlak ratio (3.2 ± 3.2; 1.1–15.6). Both ratios correlated significantly with <i>E. granulosus</i> hydatid fluid (EgHF) antibodies (SUVratio <i>r</i> = 0.73, <i>P</i> &lt; 0.001; Patlak ratio <i>r</i> = 0.85, <i>P</i> &lt; 0.001).</p> Conclusion <p>WBD PET/CT yields higher lesion-to-background contrast and may, therefore, have the potential to increase sensitivity in the assessment of hepatic AE.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Whole-body dynamic FDG-PET/CT parametric imaging in alveolar echinococcosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月6日

查看全文
  • Lars Husmann,
  • Bert-Ram Sah,
  • Fotis Kotasidis,
  • Alexander Maurer,
  • Cordula Meyer zu Schwabedissen,
  • Ansgar Deibel,
  • Martin W. Huellner

摘要

Objective

To determine the role of whole-body dynamic (WBD)/Patlak parametric 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with alveolar echinococcosis (AE). This technique allows separating metabolized from unmetabolized FDG in the blood pool and tissue, potentially providing complementary qualitative information and superior quantification to standard static PET/CT images.

Methods

We prospectively analyzed 20 PET/CT datasets performed for staging or therapy monitoring in patients with confirmed AE. Dynamic and standard static PET/CT datasets were acquired in all patients, and quantitative imaging parameters were measured in the lesion with the highest uptake (i.e., maximum standardized uptake value (SUVmax) and Patlak parameters) and compared to normal liver tissue (SUVratio and Patlak ratio).

Results

Mean SUVmax in AE manifestations was 5.7 ± 3.1 (3.2–13.9), compared to 3.2 ± 0.4 (2.5–4.2) in non-infected liver tissue, respective values for Patlak were 13.0 ± 8.6 (2.7–35.5) and 4.9 ± 2.8 (0.6–12.1). SUVratio (1.8 ± 1.1; 1.0–5.2) was significantly lower (P < 0.001) than Patlak ratio (3.2 ± 3.2; 1.1–15.6). Both ratios correlated significantly with E. granulosus hydatid fluid (EgHF) antibodies (SUVratio r = 0.73, P < 0.001; Patlak ratio r = 0.85, P < 0.001).

Conclusion

WBD PET/CT yields higher lesion-to-background contrast and may, therefore, have the potential to increase sensitivity in the assessment of hepatic AE.